Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

74.11
-1.2400-1.65%
Pre-market: 74.10-0.0103-0.01%09:24 EDT
Volume:1.42M
Turnover:105.44M
Market Cap:10.30B
PE:-10.32
High:74.89
Open:74.31
Low:73.52
Close:75.35
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.87
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-59.39
PE(LYR):-11.33

Loading ...

Cytokinetics - Demands Trial by Jury on All Triable Issues - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics - Seeks Injunction Against Litigation or Infringement Claims on Myqorzo(Aficamten) - SEC Filing

THOMSON REUTERS
·
Aug 13

Cytokinetics Sues Bristol Myers, MyoKardia Seeking Ruling on Myqorzo Patent Dispute

Reuters
·
Aug 13

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Reuters
·
Aug 13

Cytokinetics, Incorporated : JP Morgan Raises Target Price to $103 from $97

THOMSON REUTERS
·
Aug 13

Truist Financial Keeps Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
Aug 13

Cytokinetics CEO Robert I. Blum Sells 7,500 Common Shares for $575,700

Reuters
·
Aug 11

Cytokinetics is Maintained at Buy by Truist Securities

Dow Jones
·
Aug 11

Cytokinetics price target raised to $112 from $106 at Truist

TIPRANKS
·
Aug 10

Cytokinetics, Incorporated : Leerink Partners Raises Target Price to $103 from $100

THOMSON REUTERS
·
Aug 10

Truist Adjusts Price Target on Cytokinetics to $112 From $106, Maintains Buy Rating

MT Newswires Live
·
Aug 10

Cytokinetics' Q2 Beat Highlights Myqorzo Launch Strength, RBC Says

MT Newswires Live
·
Aug 08

Cytokinetics price target raised to $85 from $83 at BofA

TIPRANKS
·
Aug 07

Cytokinetics Price Target Raised to $112.00/Share from $102.00 by Needham

Dow Jones
·
Aug 07

RBC Capital Adjusts PT on Cytokinetics to $112 From $117, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Cytokinetics price target raised to $110 from $105 at Citizens

TIPRANKS
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Cytokinetics (CYTK) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 07

Cytokinetics, Incorporated Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Cytokinetics Q2 FY26 Net Loss Widens to $198.76 Million; Revenue Drops to $28.62 Million

Reuters
·
Aug 07

Cytokinetics Q2 EPS $(1.50) Beats $(1.63) Estimate, Sales $28.624M Beat $17.382M Estimate

Benzinga Earnings
·
Aug 07